<DOC>
	<DOCNO>NCT01654848</DOCNO>
	<brief_summary>In prospective observational study incidence Heparin-induced Thrombocytopenia ( HIT ) Type 2 orthotopic liver transplantation , associate factor , hemostaseological finding thrombocytes anti-body pattern go investigate .</brief_summary>
	<brief_title>Heparin-induced Thrombocytopenia ( HIT II ) Liver Transplant Recipients</brief_title>
	<detailed_description>The investigator examine frequency anti-PF4/heparin antibody ( IgG/M/A ; EIA ) functional activity ( HIPA ) 38 whole organ decease donor liver transplant recipient . Additionally , demographic , clinical , donor- recipient-specific parameter laboratory finding ( ALAT , ASAT , cholinesterase ) investigate .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>consecutive liver transplant recipients 01/2010 08/2011 transplant center allocation liver graft via Eurotransplant patient 's refusal participate prospective observation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>liver transplantation</keyword>
	<keyword>thrombocyte</keyword>
	<keyword>heparin-induced thrombocytopenia</keyword>
	<keyword>multivariate analysis associate factor HIT 2 OLT</keyword>
	<keyword>laboratory investigation HIT-antibodies</keyword>
</DOC>